EV/EBITDA
-22.12
-0.30-1.37%
Wed, 12 Mar 2025 20:08:01 GMT
Summary
- As of March 13, 2025, PLX EV/EBITDA is -22.12, with a fall of -0.30 (-1.37%) during the most recent trading day.
- Over the past year, PLX EV/EBITDA has dropped by -30.90 (-351.94%).
- PLX EV/EBITDA is now -117.35% below its all-time high of 127.48.
Performance
PLX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PLX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.4% | +1.4% | +1.2% |
| 1 m1 month | +19.1% | -19.1% | -17.0% |
| 3 m3 months | -26.7% | +26.7% | +22.4% |
| 6 m6 months | -226.3% | +77.5% | +111.3% |
| ytdytd | -22.8% | +22.7% | +19.1% |
| 1 y1 year | -351.9% | +26.0% | +47.4% |
| 5 y5 years | -144.7% | +82.2% | -6.3% |
PLX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.4% | -27.35 | +19.1% | |
| 3 m | 3-month | -15.64 | -41.4% | -27.35 | +19.1% |
| 6 m | 6-month | -6.66 | -232.1% | -27.35 | +19.1% |
| 1 y | 1-year | 8.78 | -351.9% | -27.35 | +19.1% |
| 3 y | 3-year | 10.80 | -304.8% | -27.35 | +19.1% |
| 5 y | 5-year | 127.48 | -117.3% | -83.92 | +73.6% |
| alltime | all time | 127.48 | -117.3% | -489.09 | +95.5% |
Protalix BioTherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -22.12(+22.8%) |
| 2024 | -18.02(-266.9%) |
| 2023 | 10.80(-229.3%) |
| 2022 | -8.35(+385.5%) |
| 2021 | -1.72(-104.4%) |
| 2020 | 38.73(-466.8%) |
| 2019 | -10.56(+222.0%) |
| 2018 | -3.28(+144.8%) |
| 2017 | -1.34(-53.1%) |
| 2016 | -2.86(-38.0%) |
| 2015 | -4.61(-37.4%) |
| 2014 | -7.37(-35.5%) |
| 2013 | -11.43(-79.2%) |
| Date | Value |
|---|---|
| 2012 | -54.89(+282.2%) |
| 2011 | -14.36(-51.0%) |
| 2010 | -29.31(+93.6%) |
| 2009 | -15.14(+256.2%) |
| 2008 | -4.25(-25.3%) |
| 2007 | -5.69(-93.9%) |
| 2006 | -93.19(+2593.4%) |
| 2005 | -3.46(>+9900.0%) |
| 2004 | -0.01(-99.9%) |
| 2003 | -6.70(-328.7%) |
| 2002 | 2.93(+365.1%) |
| 2001 | 0.63(-169.2%) |
| 2000 | -0.91(-82.1%) |
| 1999 | -5.09 |
FAQ
- What is Protalix BioTherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Protalix BioTherapeutics?
- What is PLX EV/EBITDA year-to-date change?
- What is Protalix BioTherapeutics EV/EBITDA year-on-year change?
What is Protalix BioTherapeutics EV/EBITDA?
The current EV/EBITDA of PLX is -22.12
What is the all time high EV/EBITDA for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high EV/EBITDA is 127.48
What is PLX EV/EBITDA year-to-date change?
Protalix BioTherapeutics EV/EBITDA has changed by -4.10 (-22.75%) since the beginning of the year
What is Protalix BioTherapeutics EV/EBITDA year-on-year change?
Over the past year, PLX EV/EBITDA has changed by -30.90 (-351.94%)